PROTEX90 CASE STUDY
"When the recommended methods, means, and procedures are followed as a matter of routine practice, these results can be achieved in all Protex90 treated healthcare facilities."
-Paul J. Pearce PhD, Specialist in Microbiology,
American Society of Clinical Pathologists, Board of Certification
SUMMARIZED STUDY RESULTS
A third party study was requested by a premier hospital in the northeast. This study was done at their hospital. Protex90 was tested in an active hospital environment by an independent microbiologist over the course of 8-weeks in 2018. The hospital wanted to see a quantifiable 15-20% reduction in bacterial contamination levels. They also requested that our applications cause minimal disruptions to the hospital.
The testing was based on the microbiological evaluation of multiple sampling sites. BPTX and the independent microbiologist designated the study, under the dynamic contact conditions, be PASS/FAIL. This meant if any bacteria were found, it would be considered a failure. After the hospital cleaning crew completed a room, the microbiologist took his samples from random areas. After the samples were taken, Protex90 was applied to the sample areas; performed by BPTX's professional team. 60 days later the microbiologist returned to take new samples.
Please note; the samples were only taken from sites that had failed the initial test.
Protex90 forms a long-lasting micro biostatic barrier on all treated surfaces (think tables, door knobs, walls, etc). To successfully cover all porous and non-porous surfaces, Protex90 is applied using a variety of foggers and electrostatic sprayers.
Each delivery method has specific advantages over one another, and are often utilized in conjunction with one another. Each team leader is trained on these advantages, and develops a unique application strategy for each customer.